insights_auto
Why is ARX down 4.00%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-4.00%(-0.020) 1D
Nov 16, 4:10:15 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.51
High
A$0.51
Low
A$0.48
Mkt. cap
166.03M
Avg. vol.
288.42K
Volume
185.28K
P/E ratio
45.80
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.51
High
A$0.51
Low
A$0.48
Mkt. cap
166.03M
Avg. vol.
288.42K
Volume
185.28K
P/E ratio
45.80
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
The Korea Times
·
1 hour ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
1 hour ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
2 hours ago
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
Stocktwits
·
1 hour ago
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd